Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Teva Pharmaceutical Industries Limited's CEO Discusses Q1 2012 Results - Earnings Call Transcript
Gene Expression & Signaling in the Immune System
Microcystic macular oedema in multiple sclerosis is associated with disease severity.
Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease.
NF-κB transcriptional activation by TNFα requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1.
Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid.
NOVANTRONE. mitoXANTRONE for injection concentrate
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-up.
Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study.
Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trial.
ARESTIN®
Receptos to initiate Phase 3 trial of RPC1063 in relapsing multiple sclerosis
Gordon Research Conference on Ion Channels
Pharmacodynamics of Dimethyl Fumarate are Tissue-specific and Involve NRF2-dependent and -independent Mechanisms.
PLEGRIDY® (Peginterferon Beta-1a) Three-Year Data Presented at AAN Annual Meeting Support Long-Term Safety and Efficacy in Multiple Sclerosis Patients
New analysis shows Novartis drug Gilenya® significantly reduced rate of brain volume loss across three large Phase III studies
A benefit-risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy.
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
GEMS Project: A Platform to Investigate Multiple Sclerosis Risk.
A Pilot Trial of Interferon beta-1a in Alzheimer's Disease
Studying both sexes: a guiding principle for biomedicine.
Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation.
Pervasive Axonal Transport Deficits in Multiple Sclerosis Models.
Differential Reconstitution of T Cell Subsets following Immunodepleting Treatment with Alemtuzumab (Anti-CD52 Monoclonal Antibody) in Patients with Relapsing-Remitting Multiple Sclerosis.
Focal vibration in neurorehabilitation.

Pages